nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—Salicylic acid—Mesalazine—Crohn's disease	0.281	1	CrCrCtD
Meclofenamic acid—PTGS2—Crohn's disease	0.158	1	CbGaD
Meclofenamic acid—ALOX5—Balsalazide—Crohn's disease	0.153	0.299	CbGbCtD
Meclofenamic acid—ALOX5—Mesalazine—Crohn's disease	0.122	0.239	CbGbCtD
Meclofenamic acid—ALOX5—Sulfasalazine—Crohn's disease	0.0684	0.133	CbGbCtD
Meclofenamic acid—PTGS2—Balsalazide—Crohn's disease	0.0407	0.0795	CbGbCtD
Meclofenamic acid—PTGS1—Balsalazide—Crohn's disease	0.0344	0.0671	CbGbCtD
Meclofenamic acid—PTGS2—Mesalazine—Crohn's disease	0.0326	0.0635	CbGbCtD
Meclofenamic acid—PTGS1—Mesalazine—Crohn's disease	0.0275	0.0537	CbGbCtD
Meclofenamic acid—PTGS2—Sulfasalazine—Crohn's disease	0.0182	0.0355	CbGbCtD
Meclofenamic acid—PTGS1—Sulfasalazine—Crohn's disease	0.0154	0.03	CbGbCtD
Meclofenamic acid—ALOX5—Synthesis of 5-eicosatetraenoic acids—GPX4—Crohn's disease	0.00289	0.129	CbGpPWpGaD
Meclofenamic acid—Niclosamide—STAT3—Crohn's disease	0.00192	0.578	CrCbGaD
Meclofenamic acid—Lupus erythematosus—Mesalazine—Crohn's disease	0.00128	0.0598	CcSEcCtD
Meclofenamic acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00115	0.051	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00115	0.051	CbGpPWpGaD
Meclofenamic acid—Erythema nodosum—Mesalazine—Crohn's disease	0.0011	0.0515	CcSEcCtD
Meclofenamic acid—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000996	0.0444	CbGpPWpGaD
Meclofenamic acid—Ulcer—Mercaptopurine—Crohn's disease	0.000928	0.0434	CcSEcCtD
Meclofenamic acid—Systemic lupus erythematosus—Mesalazine—Crohn's disease	0.00086	0.0402	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transport of organic anions—ALB—Crohn's disease	0.000702	0.0312	CbGpPWpGaD
Meclofenamic acid—Jaundice cholestatic—Azathioprine—Crohn's disease	0.000595	0.0278	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Mesalazine—Crohn's disease	0.000542	0.0253	CcSEcCtD
Meclofenamic acid—ALOX5—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000531	0.0236	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000529	0.0235	CbGpPWpGaD
Meclofenamic acid—Colitis—Azathioprine—Crohn's disease	0.000502	0.0235	CcSEcCtD
Meclofenamic acid—Stomatitis—Mercaptopurine—Crohn's disease	0.000478	0.0224	CcSEcCtD
Meclofenamic acid—Colitis—Mesalazine—Crohn's disease	0.000457	0.0214	CcSEcCtD
Meclofenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000455	0.0203	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	0.000394	0.0175	CbGpPWpGaD
Meclofenamic acid—Alopecia—Mercaptopurine—Crohn's disease	0.000389	0.0182	CcSEcCtD
Meclofenamic acid—Leukopenia—Mercaptopurine—Crohn's disease	0.000343	0.016	CcSEcCtD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000338	0.015	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000322	0.0143	CbGpPWpGaD
Meclofenamic acid—Oedema—Mercaptopurine—Crohn's disease	0.000313	0.0146	CcSEcCtD
Meclofenamic acid—Diclofenac—CXCL8—Crohn's disease	0.000311	0.0934	CrCbGaD
Meclofenamic acid—Anorexia—Mercaptopurine—Crohn's disease	0.000298	0.0139	CcSEcCtD
Meclofenamic acid—Eosinophilia—Mesalazine—Crohn's disease	0.000296	0.0138	CcSEcCtD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000295	0.0131	CbGpPWpGaD
Meclofenamic acid—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00029	0.0136	CcSEcCtD
Meclofenamic acid—Neutropenia—Mesalazine—Crohn's disease	0.000279	0.0131	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Azathioprine—Crohn's disease	0.000273	0.0128	CcSEcCtD
Meclofenamic acid—Decreased appetite—Mercaptopurine—Crohn's disease	0.000272	0.0127	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00027	0.0126	CcSEcCtD
Meclofenamic acid—Ulcer—Prednisone—Crohn's disease	0.000266	0.0125	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000264	0.0123	CcSEcCtD
Meclofenamic acid—Haemoglobin—Azathioprine—Crohn's disease	0.000264	0.0123	CcSEcCtD
Meclofenamic acid—Haemorrhage—Azathioprine—Crohn's disease	0.000262	0.0123	CcSEcCtD
Meclofenamic acid—Renal failure—Mesalazine—Crohn's disease	0.000262	0.0122	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.00026	0.0116	CbGpPWpGaD
Meclofenamic acid—Stomatitis—Mesalazine—Crohn's disease	0.00026	0.0121	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Mesalazine—Crohn's disease	0.000259	0.0121	CcSEcCtD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—MPO—Crohn's disease	0.000257	0.0115	CbGpPWpGaD
Meclofenamic acid—ALOX5—Eicosanoid Synthesis—PTGS2—Crohn's disease	0.000257	0.0114	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000249	0.0111	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000249	0.0111	CbGpPWpGaD
Meclofenamic acid—Agranulocytosis—Mesalazine—Crohn's disease	0.000249	0.0116	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Azathioprine—Crohn's disease	0.000248	0.0116	CcSEcCtD
Meclofenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000247	0.011	CbGpPWpGaD
Meclofenamic acid—Haemoglobin—Mesalazine—Crohn's disease	0.00024	0.0112	CcSEcCtD
Meclofenamic acid—Haemorrhage—Mesalazine—Crohn's disease	0.000239	0.0112	CcSEcCtD
Meclofenamic acid—Alopecia—Azathioprine—Crohn's disease	0.000232	0.0108	CcSEcCtD
Meclofenamic acid—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00023	0.0102	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000229	0.0102	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000229	0.0102	CbGpPWpGaD
Meclofenamic acid—Erythema multiforme—Mesalazine—Crohn's disease	0.000226	0.0106	CcSEcCtD
Meclofenamic acid—Tinnitus—Mesalazine—Crohn's disease	0.000223	0.0104	CcSEcCtD
Meclofenamic acid—Diarrhoea—Mercaptopurine—Crohn's disease	0.000214	0.01	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Azathioprine—Crohn's disease	0.000212	0.00991	CcSEcCtD
Meclofenamic acid—AKR1C3—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000211	0.00941	CbGpPWpGaD
Meclofenamic acid—Alopecia—Mesalazine—Crohn's disease	0.000211	0.00988	CcSEcCtD
Meclofenamic acid—Lumiracoxib—PTGS2—Crohn's disease	0.000208	0.0626	CrCbGaD
Meclofenamic acid—Malaise—Azathioprine—Crohn's disease	0.000206	0.00963	CcSEcCtD
Meclofenamic acid—Leukopenia—Azathioprine—Crohn's disease	0.000205	0.00956	CcSEcCtD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	0.0002	0.00891	CbGpPWpGaD
Meclofenamic acid—Vomiting—Mercaptopurine—Crohn's disease	0.000199	0.0093	CcSEcCtD
Meclofenamic acid—Vision blurred—Mesalazine—Crohn's disease	0.000196	0.00917	CcSEcCtD
Meclofenamic acid—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000196	0.00872	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metapathway biotransformation—GPX4—Crohn's disease	0.000194	0.00864	CbGpPWpGaD
Meclofenamic acid—Ill-defined disorder—Mesalazine—Crohn's disease	0.000193	0.00903	CcSEcCtD
Meclofenamic acid—Discomfort—Azathioprine—Crohn's disease	0.000192	0.00899	CcSEcCtD
Meclofenamic acid—Malaise—Mesalazine—Crohn's disease	0.000188	0.00878	CcSEcCtD
Meclofenamic acid—Leukopenia—Mesalazine—Crohn's disease	0.000186	0.00871	CcSEcCtD
Meclofenamic acid—Nausea—Mercaptopurine—Crohn's disease	0.000186	0.00869	CcSEcCtD
Meclofenamic acid—Palpitations—Mesalazine—Crohn's disease	0.000184	0.0086	CcSEcCtD
Meclofenamic acid—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000183	0.00813	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000176	0.00782	CbGpPWpGaD
Meclofenamic acid—Discomfort—Mesalazine—Crohn's disease	0.000175	0.00819	CcSEcCtD
Meclofenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	0.000171	0.00763	CbGpPWpGaD
Meclofenamic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	0.000171	0.00763	CbGpPWpGaD
Meclofenamic acid—Oedema—Mesalazine—Crohn's disease	0.00017	0.00794	CcSEcCtD
Meclofenamic acid—Salsalate—PTGS2—Crohn's disease	0.000165	0.0495	CrCbGaD
Meclofenamic acid—Anorexia—Mesalazine—Crohn's disease	0.000162	0.00757	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000161	0.00753	CcSEcCtD
Meclofenamic acid—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	0.000159	0.00707	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000155	0.00691	CbGpPWpGaD
Meclofenamic acid—Feeling abnormal—Azathioprine—Crohn's disease	0.000154	0.00718	CcSEcCtD
Meclofenamic acid—Insomnia—Mesalazine—Crohn's disease	0.000154	0.00718	CcSEcCtD
Meclofenamic acid—Paraesthesia—Mesalazine—Crohn's disease	0.000153	0.00713	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000152	0.00713	CcSEcCtD
Meclofenamic acid—Neutropenia—Prednisone—Crohn's disease	0.000148	0.00691	CcSEcCtD
Meclofenamic acid—Decreased appetite—Mesalazine—Crohn's disease	0.000148	0.0069	CcSEcCtD
Meclofenamic acid—Abdominal pain—Azathioprine—Crohn's disease	0.000147	0.00689	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000147	0.00686	CcSEcCtD
Meclofenamic acid—Fatigue—Mesalazine—Crohn's disease	0.000146	0.00685	CcSEcCtD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000146	0.00652	CbGpPWpGaD
Meclofenamic acid—Constipation—Mesalazine—Crohn's disease	0.000145	0.00679	CcSEcCtD
Meclofenamic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000143	0.00636	CbGpPWpGaD
Meclofenamic acid—ALOX5—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000143	0.00635	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000142	0.00633	CbGpPWpGaD
Meclofenamic acid—Feeling abnormal—Mesalazine—Crohn's disease	0.00014	0.00654	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000139	0.00649	CcSEcCtD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—CRP—Crohn's disease	0.000135	0.00603	CbGpPWpGaD
Meclofenamic acid—Urticaria—Mesalazine—Crohn's disease	0.000135	0.00631	CcSEcCtD
Meclofenamic acid—Abdominal pain—Mesalazine—Crohn's disease	0.000134	0.00628	CcSEcCtD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	0.000134	0.00597	CbGpPWpGaD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.00013	0.00579	CbGpPWpGaD
Meclofenamic acid—Diarrhoea—Azathioprine—Crohn's disease	0.000128	0.00597	CcSEcCtD
Meclofenamic acid—Haemoglobin—Prednisone—Crohn's disease	0.000127	0.00594	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000127	0.00564	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000127	0.00564	CbGpPWpGaD
Meclofenamic acid—Haemorrhage—Prednisone—Crohn's disease	0.000127	0.00591	CcSEcCtD
Meclofenamic acid—Mefenamic acid—PTGS2—Crohn's disease	0.000126	0.0379	CrCbGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000124	0.00554	CbGpPWpGaD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—Crohn's disease	0.000123	0.0369	CrCbGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000122	0.00544	CbGpPWpGaD
Meclofenamic acid—Asthenia—Mesalazine—Crohn's disease	0.000122	0.0057	CcSEcCtD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000122	0.00542	CbGpPWpGaD
Meclofenamic acid—Pruritus—Mesalazine—Crohn's disease	0.00012	0.00562	CcSEcCtD
Meclofenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	0.00012	0.00535	CbGpPWpGaD
Meclofenamic acid—Vomiting—Azathioprine—Crohn's disease	0.000119	0.00554	CcSEcCtD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000116	0.00517	CbGpPWpGaD
Meclofenamic acid—Diarrhoea—Mesalazine—Crohn's disease	0.000116	0.00543	CcSEcCtD
Meclofenamic acid—Alopecia—Prednisone—Crohn's disease	0.000112	0.00523	CcSEcCtD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	0.000112	0.00497	CbGpPWpGaD
Meclofenamic acid—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	0.000111	0.00496	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	0.000111	0.00494	CbGpPWpGaD
Meclofenamic acid—Nausea—Azathioprine—Crohn's disease	0.000111	0.00518	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—ALB—Crohn's disease	0.000109	0.0329	CrCbGaD
Meclofenamic acid—Vomiting—Mesalazine—Crohn's disease	0.000108	0.00505	CcSEcCtD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000104	0.00464	CbGpPWpGaD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000104	0.00464	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000104	0.00463	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—ALB—Crohn's disease	0.000104	0.00462	CbGpPWpGaD
Meclofenamic acid—Vision blurred—Prednisone—Crohn's disease	0.000104	0.00485	CcSEcCtD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000104	0.00461	CbGpPWpGaD
Meclofenamic acid—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000103	0.0046	CbGpPWpGaD
Meclofenamic acid—Ill-defined disorder—Prednisone—Crohn's disease	0.000102	0.00478	CcSEcCtD
Meclofenamic acid—Salicylic acid—PTGS2—Crohn's disease	0.000101	0.0304	CrCbGaD
Meclofenamic acid—Nausea—Mesalazine—Crohn's disease	0.000101	0.00472	CcSEcCtD
Meclofenamic acid—Malaise—Prednisone—Crohn's disease	9.93e-05	0.00464	CcSEcCtD
Meclofenamic acid—AKR1C3—smooth muscle tissue—Crohn's disease	9.88e-05	0.0967	CbGeAlD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—IFNG—Crohn's disease	9.47e-05	0.00422	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	9.37e-05	0.00417	CbGpPWpGaD
Meclofenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	9.31e-05	0.00415	CbGpPWpGaD
Meclofenamic acid—Discomfort—Prednisone—Crohn's disease	9.26e-05	0.00433	CcSEcCtD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	9.2e-05	0.00409	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—PTGS2—Crohn's disease	9.08e-05	0.00404	CbGpPWpGaD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	9.06e-05	0.00403	CbGpPWpGaD
Meclofenamic acid—Diclofenac—PTGS2—Crohn's disease	9.06e-05	0.0272	CrCbGaD
Meclofenamic acid—Salicylic acid—ALB—Crohn's disease	9.02e-05	0.0271	CrCbGaD
Meclofenamic acid—Oedema—Prednisone—Crohn's disease	8.99e-05	0.0042	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.92e-05	0.00397	CbGpPWpGaD
Meclofenamic acid—AKR1C3—mammalian vulva—Crohn's disease	8.9e-05	0.0871	CbGeAlD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	8.86e-05	0.00395	CbGpPWpGaD
Meclofenamic acid—ALOX5—smooth muscle tissue—Crohn's disease	8.71e-05	0.0852	CbGeAlD
Meclofenamic acid—Anorexia—Prednisone—Crohn's disease	8.57e-05	0.00401	CcSEcCtD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—IL1B—Crohn's disease	8.45e-05	0.00376	CbGpPWpGaD
Meclofenamic acid—Insomnia—Prednisone—Crohn's disease	8.13e-05	0.0038	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.1e-05	0.00361	CbGpPWpGaD
Meclofenamic acid—Diclofenac—ALB—Crohn's disease	8.07e-05	0.0243	CrCbGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.07e-05	0.00359	CbGpPWpGaD
Meclofenamic acid—Paraesthesia—Prednisone—Crohn's disease	8.07e-05	0.00377	CcSEcCtD
Meclofenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	7.92e-05	0.00353	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.89e-05	0.00351	CbGpPWpGaD
Meclofenamic acid—Decreased appetite—Prednisone—Crohn's disease	7.81e-05	0.00365	CcSEcCtD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	7.77e-05	0.00346	CbGpPWpGaD
Meclofenamic acid—Fatigue—Prednisone—Crohn's disease	7.75e-05	0.00362	CcSEcCtD
Meclofenamic acid—Constipation—Prednisone—Crohn's disease	7.69e-05	0.00359	CcSEcCtD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.59e-05	0.00338	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.56e-05	0.00336	CbGpPWpGaD
Meclofenamic acid—Feeling abnormal—Prednisone—Crohn's disease	7.41e-05	0.00346	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Prednisone—Crohn's disease	7.35e-05	0.00344	CcSEcCtD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	7.35e-05	0.00327	CbGpPWpGaD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	7.31e-05	0.00325	CbGpPWpGaD
Meclofenamic acid—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	7.19e-05	0.0032	CbGpPWpGaD
Meclofenamic acid—Urticaria—Prednisone—Crohn's disease	7.14e-05	0.00334	CcSEcCtD
Meclofenamic acid—Abdominal pain—Prednisone—Crohn's disease	7.1e-05	0.00332	CcSEcCtD
Meclofenamic acid—ALOX5—lymphoid tissue—Crohn's disease	6.96e-05	0.0681	CbGeAlD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	6.93e-05	0.00308	CbGpPWpGaD
Meclofenamic acid—ALOX5—digestive system—Crohn's disease	6.88e-05	0.0673	CbGeAlD
Meclofenamic acid—PTGS2—gall bladder—Crohn's disease	6.7e-05	0.0656	CbGeAlD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	6.49e-05	0.00289	CbGpPWpGaD
Meclofenamic acid—Asthenia—Prednisone—Crohn's disease	6.45e-05	0.00301	CcSEcCtD
Meclofenamic acid—Pruritus—Prednisone—Crohn's disease	6.36e-05	0.00297	CcSEcCtD
Meclofenamic acid—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	6.19e-05	0.00275	CbGpPWpGaD
Meclofenamic acid—Diarrhoea—Prednisone—Crohn's disease	6.15e-05	0.00288	CcSEcCtD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—TNF—Crohn's disease	6.13e-05	0.00273	CbGpPWpGaD
Meclofenamic acid—PTGS2—mouth—Crohn's disease	5.96e-05	0.0583	CbGeAlD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	5.87e-05	0.00261	CbGpPWpGaD
Meclofenamic acid—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	5.81e-05	0.00258	CbGpPWpGaD
Meclofenamic acid—Vomiting—Prednisone—Crohn's disease	5.71e-05	0.00267	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—RSPO3—Crohn's disease	5.66e-05	0.00252	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—SMAD3—Crohn's disease	5.61e-05	0.00249	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—SMAD3—Crohn's disease	5.61e-05	0.00249	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.59e-05	0.00249	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PLA2G4F—Crohn's disease	5.45e-05	0.00242	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PLA2G4F—Crohn's disease	5.43e-05	0.00242	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	5.4e-05	0.0024	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SEL1L—Crohn's disease	5.37e-05	0.00239	CbGpPWpGaD
Meclofenamic acid—Nausea—Prednisone—Crohn's disease	5.34e-05	0.0025	CcSEcCtD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.3e-05	0.00236	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.3e-05	0.00236	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.3e-05	0.00236	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ACKR2—Crohn's disease	5.23e-05	0.00233	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	5.13e-05	0.00228	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—TYK2—Crohn's disease	5.12e-05	0.00228	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—TYK2—Crohn's disease	5.12e-05	0.00228	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MLN—Crohn's disease	4.96e-05	0.00221	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—IL6—Crohn's disease	4.95e-05	0.0022	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—JAK2—Crohn's disease	4.89e-05	0.00218	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—JAK2—Crohn's disease	4.89e-05	0.00218	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—lymph node—Crohn's disease	4.85e-05	0.0475	CbGeAlD
Meclofenamic acid—AKR1C3—Disease—LTF—Crohn's disease	4.82e-05	0.00214	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	4.77e-05	0.00212	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	4.66e-05	0.00208	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—MTMR3—Crohn's disease	4.63e-05	0.00206	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—MTMR3—Crohn's disease	4.61e-05	0.00205	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TAGAP—Crohn's disease	4.54e-05	0.00202	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.51e-05	0.00201	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	4.5e-05	0.002	CbGpPWpGaD
Meclofenamic acid—AKR1C3—lymph node—Crohn's disease	4.46e-05	0.0436	CbGeAlD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	4.29e-05	0.00191	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.21e-05	0.00187	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	4.11e-05	0.00183	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RSPO3—Crohn's disease	3.97e-05	0.00177	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	3.94e-05	0.00175	CbGpPWpGaD
Meclofenamic acid—ALOX5—lymph node—Crohn's disease	3.93e-05	0.0384	CbGeAlD
Meclofenamic acid—AKR1C3—Disease—GCKR—Crohn's disease	3.88e-05	0.00173	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.8e-05	0.00169	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SEL1L—Crohn's disease	3.76e-05	0.00167	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.73e-05	0.00166	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	3.66e-05	0.00163	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—TYK2—Crohn's disease	3.66e-05	0.00163	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—TYK2—Crohn's disease	3.66e-05	0.00163	CbGpPWpGaD
Meclofenamic acid—PTGS1—epithelium—Crohn's disease	3.63e-05	0.0355	CbGeAlD
Meclofenamic acid—ALOX5—Metabolism—FADS1—Crohn's disease	3.61e-05	0.00161	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—FADS1—Crohn's disease	3.59e-05	0.0016	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.58e-05	0.00159	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	3.57e-05	0.00159	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	3.55e-05	0.00158	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	3.53e-05	0.00157	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.51e-05	0.00156	CbGpPWpGaD
Meclofenamic acid—PTGS1—smooth muscle tissue—Crohn's disease	3.5e-05	0.0342	CbGeAlD
Meclofenamic acid—KCNQ3—Developmental Biology—JAK2—Crohn's disease	3.49e-05	0.00155	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—JAK2—Crohn's disease	3.49e-05	0.00155	CbGpPWpGaD
Meclofenamic acid—PTGS2—epithelium—Crohn's disease	3.47e-05	0.0339	CbGeAlD
Meclofenamic acid—PTGS1—skin of body—Crohn's disease	3.45e-05	0.0338	CbGeAlD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCR9—Crohn's disease	3.44e-05	0.00153	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SLC11A1—Crohn's disease	3.43e-05	0.00153	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	3.39e-05	0.00151	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GPX4—Crohn's disease	3.38e-05	0.0015	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GPX4—Crohn's disease	3.37e-05	0.0015	CbGpPWpGaD
Meclofenamic acid—PTGS2—smooth muscle tissue—Crohn's disease	3.34e-05	0.0327	CbGeAlD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	3.32e-05	0.00148	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.3e-05	0.00147	CbGpPWpGaD
Meclofenamic acid—PTGS2—skin of body—Crohn's disease	3.3e-05	0.0323	CbGeAlD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.29e-05	0.00146	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	3.27e-05	0.00145	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GCKR—Crohn's disease	3.26e-05	0.00145	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	3.26e-05	0.00145	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GCKR—Crohn's disease	3.25e-05	0.00145	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—GPR65—Crohn's disease	3.2e-05	0.00142	CbGpPWpGaD
Meclofenamic acid—PTGS1—mammalian vulva—Crohn's disease	3.15e-05	0.0308	CbGeAlD
Meclofenamic acid—AKR1C3—Disease—RBX1—Crohn's disease	2.94e-05	0.00131	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HSPA1B—Crohn's disease	2.94e-05	0.00131	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	2.91e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.84e-05	0.00126	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.79e-05	0.00124	CbGpPWpGaD
Meclofenamic acid—PTGS1—digestive system—Crohn's disease	2.76e-05	0.027	CbGeAlD
Meclofenamic acid—PTGS2—lymphoid tissue—Crohn's disease	2.67e-05	0.0261	CbGeAlD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	2.66e-05	0.00118	CbGpPWpGaD
Meclofenamic acid—PTGS2—digestive system—Crohn's disease	2.64e-05	0.0258	CbGeAlD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.61e-05	0.00116	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—UBE2D1—Crohn's disease	2.58e-05	0.00115	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	2.58e-05	0.00115	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—STAT3—Crohn's disease	2.56e-05	0.00114	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—STAT3—Crohn's disease	2.56e-05	0.00114	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—IL6—Crohn's disease	2.51e-05	0.00112	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—IL6—Crohn's disease	2.51e-05	0.00112	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	2.4e-05	0.00107	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PLA2G4F—Crohn's disease	2.36e-05	0.00105	CbGpPWpGaD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.34e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.33e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.32e-05	0.00103	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	2.3e-05	0.00102	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCR6—Crohn's disease	2.28e-05	0.00101	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—TNF—Crohn's disease	2.22e-05	0.000986	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—TNF—Crohn's disease	2.22e-05	0.000986	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	2.15e-05	0.000955	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	2.11e-05	0.000939	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RBX1—Crohn's disease	2.06e-05	0.000917	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.04e-05	0.000908	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.03e-05	0.000905	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTMR3—Crohn's disease	2.01e-05	0.000894	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTGER4—Crohn's disease	2.01e-05	0.000893	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RSPO3—Crohn's disease	1.96e-05	0.000871	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.87e-05	0.000835	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SEL1L—Crohn's disease	1.86e-05	0.000826	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SMAD3—Crohn's disease	1.85e-05	0.000821	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—UBE2D1—Crohn's disease	1.81e-05	0.000804	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—IL6—Crohn's disease	1.79e-05	0.000796	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—IL6—Crohn's disease	1.79e-05	0.000796	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RIPK2—Crohn's disease	1.75e-05	0.00078	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL3—Crohn's disease	1.71e-05	0.00076	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	1.7e-05	0.000758	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	1.67e-05	0.000743	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—LTF—Crohn's disease	1.66e-05	0.000741	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RASGRP1—Crohn's disease	1.65e-05	0.000735	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTMR3—Crohn's disease	1.59e-05	0.00071	CbGpPWpGaD
Meclofenamic acid—PTGS1—lymph node—Crohn's disease	1.58e-05	0.0154	CbGeAlD
Meclofenamic acid—PTGS1—Metabolism—FADS1—Crohn's disease	1.56e-05	0.000696	CbGpPWpGaD
Meclofenamic acid—PTGS2—lymph node—Crohn's disease	1.51e-05	0.0147	CbGeAlD
Meclofenamic acid—AKR1C3—Signaling Pathways—SOCS1—Crohn's disease	1.5e-05	0.000666	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GPX4—Crohn's disease	1.46e-05	0.000652	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GCKR—Crohn's disease	1.41e-05	0.00063	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	1.35e-05	0.000599	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GCKR—Crohn's disease	1.34e-05	0.000597	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SMAD3—Crohn's disease	1.29e-05	0.000575	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—FADS1—Crohn's disease	1.24e-05	0.000553	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TYK2—Crohn's disease	1.2e-05	0.000536	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL2RA—Crohn's disease	1.2e-05	0.000533	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.19e-05	0.000529	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC11A1—Crohn's disease	1.19e-05	0.000528	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GPX4—Crohn's disease	1.16e-05	0.000518	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—JAK2—Crohn's disease	1.15e-05	0.000511	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.14e-05	0.000505	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GCKR—Crohn's disease	1.12e-05	0.0005	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CD4—Crohn's disease	1.09e-05	0.000485	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—Crohn's disease	1.08e-05	0.000481	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ALB—Crohn's disease	1.04e-05	0.000462	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ALB—Crohn's disease	1.03e-05	0.00046	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RBX1—Crohn's disease	1.02e-05	0.000452	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HSPA1B—Crohn's disease	1.02e-05	0.000452	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.01e-05	0.00045	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—Crohn's disease	9.09e-06	0.000404	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—Crohn's disease	9.05e-06	0.000403	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—UBE2D1—Crohn's disease	8.91e-06	0.000397	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.85e-06	0.000394	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TYK2—Crohn's disease	8.43e-06	0.000375	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—STAT3—Crohn's disease	8.43e-06	0.000375	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JAK2—Crohn's disease	8.04e-06	0.000358	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.03e-06	0.000357	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CXCL8—Crohn's disease	7.34e-06	0.000327	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SMAD3—Crohn's disease	6.38e-06	0.000284	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—STAT3—Crohn's disease	5.9e-06	0.000263	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—Crohn's disease	5.89e-06	0.000262	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALB—Crohn's disease	4.5e-06	0.0002	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TYK2—Crohn's disease	4.16e-06	0.000185	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—Crohn's disease	4.12e-06	0.000184	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—JAK2—Crohn's disease	3.97e-06	0.000177	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—Crohn's disease	3.94e-06	0.000175	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CD4—Crohn's disease	3.76e-06	0.000167	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALB—Crohn's disease	3.57e-06	0.000159	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT3—Crohn's disease	2.91e-06	0.00013	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—Crohn's disease	2.03e-06	9.06e-05	CbGpPWpGaD
